Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pharmaxis Ltd (AU:PXS)
ASX:PXS
Pharmaxis Ltd (PXS) Share Price & Analysis
0 Followers
PXS Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.03 - AU$0.07
Previous CloseAU$0.03
Volume21.67K
Average Volume (3M)173.00K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)AU$8.94M
Total Debt (Recent Filing)AU$4.29M
Price to Earnings (P/E)-1.6
Beta1.07
Next Earnings
Feb 08, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding722,614,210
10 Day Avg. Volume2,290,257
30 Day Avg. Volume172,996
Standard Deviation0.14
R-Squared0.03
Alpha-0.00747
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
5.18%
Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
94.82% Public Companies and
Individual Investors
PXS FAQ
What was Pharmaxis Ltd’s price range in the past 12 months?
Pharmaxis Ltd lowest share price was AU$0.03 and its highest was AU$0.07 in the past 12 months.
What is Pharmaxis Ltd’s market cap?
Currently, no data Available
When is Pharmaxis Ltd’s upcoming earnings report date?
Pharmaxis Ltd’s upcoming earnings report date is Feb 08, 2024 which is 70 days ago.
How were Pharmaxis Ltd’s earnings last quarter?
Pharmaxis Ltd released its earnings results on Aug 28, 2023. The company reported -AU$0.009 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.009.
Is Pharmaxis Ltd overvalued?
According to Wall Street analysts Pharmaxis Ltd’s price is currently Overvalued.
Does Pharmaxis Ltd pay dividends?
Pharmaxis Ltd does not currently pay dividends.
What is Pharmaxis Ltd’s EPS estimate?
Pharmaxis Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pharmaxis Ltd have?
Pharmaxis Ltd has 722,614,200 shares outstanding.
What happened to Pharmaxis Ltd’s price movement after its last earnings report?
Pharmaxis Ltd reported an EPS of -AU$0.009 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Pharmaxis Ltd?
Currently, no hedge funds are holding shares in AU:PXS
---
Pharmaxis Ltd Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:PXS Sentiment 85%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-56.45%
12-Months-Change
Fundamentals
Return on Equity
-111.57%
Trailing 12-Months
Asset Growth
-4.61%
Trailing 12-Months
Company Description
Pharmaxis Ltd
Pharmaxis Ltd is an Australia based pharmaceutical research company engaged in the research, development, and commercialization of human healthcare products for the treatment and management of fibrotic and inflammatory diseases. The firm's research efforts are focused on discovering drugs to treat inflammatory and fibrotic diseases such as NASH, pulmonary fibrosis, kidney and liver fibrosis and cancer from its amine oxidase inhibitor chemistry platform. Its product pipeline also includes Orbital and ASM8. The operating segments are Mannitol respiratory business and New Drug Development. It generates maximum revenue from Mannitol respiratory business segment.
---
PXS Stock 12 Months Forecast
Average Price Target
―Technical Analysis
PainChek Ltd
―
Invex Therapeutics Ltd.
―
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
―
Best Analysts Covering PXS
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-40.00%
reiterated a buy rating 8 months ago
Copying Derek Jellinek's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -40.00% per trade.
---